hotspot -WSS

hotspot

author：fashion 2025-10-03 00:37:52 - browse：42

Person wearing a smart watch. -- first opinion coverage from STAT — Adobe

The Apple Watch has secured a new qualification from the Food and Drug Administration that could make the smartwatch an appealing tool for medical device companies hoping to illustrate the benefits of a common heart procedure.

Last week, the Apple Watch’s Atrial Fibrillation History feature became the first digital tool qualified under the Medical Device Development Tools (MDDT) program. Released in 2022, the feature estimates a user’s A-fib burden, or how much time they spend in atrial fibrillation, which is an irregular heart rhythm that can cause shortness of breath and fatigue, and is also linked to an increased risk of stroke.

The qualification means that FDA has determined in advance that sponsors can use the feature as a secondary endpoint in clinical trials without having to do additional work. Specifically, the Apple Watch is qualified for use as a secondary endpoint in clinical trials for cardiac ablation devices, which reduce the electrical signals that cause A-fib by scarring the heart with extreme heat or cold energy. Pulsed field ablation is the latest version of the technology, using a controlled electric field to scar tissue rather than the riskier thermal energy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： How I helped Pfizer think through the ethics of Viagra

hotspot

focus

WSS

How I helped Pfizer think through the ethics of Viagra

CDC launches VaccineFinder tool to locate Covid

CDC recommends RSV monoclonal antibody for infants

Group behind ProMed defends move to subscription

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Pharma showers House GOP doctor with campaign cash

leisure time

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Guidelines to prevent youth baseball injuries need more muscle

FDA approves Sage Therapeutics’ rapid

Walensky prepares to leave CDC — and Congress — behind

Alnylam reports growth in sales of rare disease treatments

As demand for Covid shots wanes, Moderna seeks its next success

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

As demand for Covid shots wanes, Moderna seeks its next success

Hospitals use virtual reality to design more inclusive rooms for kids

Tori Bowie and the unacceptable rates of Black maternal death

Study links childhood stress with decline in older age

hotspot

When waiting feels immoral: Empathy in the emergency department

Judge rejects Trump's counterclaim against E. Jean Carroll

An Ebola outbreak presents a new mystery involving children

Late stage cancers on the rise after pandemic delayed screenings

Lessons Learned: This is why you network to find that industry job you want

Physicians aren't 'burning out.' They're suffering from moral injury

hotspot

entertainment

focus

hotspot